Henry Schein, Inc. (HSIC) reported third-quarter 2025 net sales of $3.34 billion, up 5.4% year-over-year, surpassing analysts' expectations by 1.9%. The company's adjusted earnings per share increased to $1.38, reflecting a 13.1% rise from the previous year, prompting Henry Schein to raise its full-year 2025 adjusted EPS forecast to between $4.88 and $4.96. Despite a drop in cash reserves to $136 million, HSIC shares have outperformed the industry with a 15.4% rally.
“Henry Schein · reported revenues of · 3.34 billion · up 5.2% year on year”
“Henry Schein · exceeded analysts’ expectations by · 1.9% · in revenue”
“Henry Schein · is a global distributor of · healthcare products and services · primarily to dental practices”
“Henry Schein, Inc. (HSIC) · registered · third-quarter 2025 adjusted earnings per share (EPS) · $1.38”
“Henry Schein · reported net sales of · $3.34 billion · up 5.4% year over year”
“Henry Schein · exited the third quarter of 2025 with cash and cash equivalents of · $136 million · compared to $145 million at the end of the second quarter”
“HSIC · repurchased nearly · 3.3 million shares of its common stock · for approximately $229 million”
“Henry Schein · raised its full-year 2025 adjusted EPS forecast to the range of · $4.88 to $4.96 · earlier $4.80-$4.94”
“Henry Schein · reported revenues of · $3.34 billion · up 5.2% year on year”
“Henry Schein · exceeded analysts’ expectations by · 1.9%”
“Henry Schein · is a global distributor of · healthcare products and services · primarily to dental practices, medical offices, and other healthcare facilities”
“Henry Schein’s share price · has · 30-day share price return · 15.7%”